Dec 7 (Reuters) - Mesoblast Ltd MSB.AX :
* MESOBLAST LTD - ANNOUNCED RESULTS PRESENTED AT 62ND ANNUAL MEETING AMERICAN SOCIETY OF HEMATOLOGY
* MESOBLAST LTD - REMESTEMCEL-L REDUCES INFLAMMATORY BIOMARKERS PREDICTIVE OF HIGH MORTALITY IN ACUTE GRAFT VERSUS HOST DISEASE